Results

eNauka >  Results >  Efficiency of second-line BRAF/MEK inhibitors in BRAFV600 mutated metastatic melanoma patients after first-line immunotherapy failure: A EUMelaReg real-world study
Title: Efficiency of second-line BRAF/MEK inhibitors in BRAFV600 mutated metastatic melanoma patients after first-line immunotherapy failure: A EUMelaReg real-world study
Authors Ellebaek, E; ...; Dujovic, B; ...; (broj, koautora 20)
Issue Date: 2025
Publication: ANNALS OF ONCOLOGY
ISSN: 0923-7534 Annals of Oncology Search Idenfier
Type: Conference Paper
Collation: vol. 36 str. S976-S977
DOI: 10.1016/j.annonc.2025.08.2274
WoS-ID: 001634626200046
URI: https://enauka.gov.rs/handle/123456789/1019102
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.